[
  {
    "title": "达安基因(002030.SZ)：实时荧光定量PCR分析仪取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/23155237234254.shtml",
    "datetime": "2022-12-23 15:52:56",
    "code": "002030"
  },
  {
    "title": "达安基因拟新增竞拍用地及后续投资建设追加投资金额5亿 追加投资后项目总投资额不超过15亿",
    "href": "http://stock.jrj.com.cn/2022/12/13195037209946.shtml",
    "datetime": "2022-12-13 19:50:54",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：拟追加与广州开发区投资促进局合作项目投资金额5亿元",
    "href": "http://stock.jrj.com.cn/2022/12/13175837209515.shtml",
    "datetime": "2022-12-13 17:58:51",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：结核分枝杆菌复合群核酸检测试剂盒(PCR-荧光探针法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/13174937209478.shtml",
    "datetime": "2022-12-13 17:49:59",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：拟对建设科研生产综合大楼追加投资不超1亿元",
    "href": "http://stock.jrj.com.cn/2022/12/13174737209487.shtml",
    "datetime": "2022-12-13 17:47:41",
    "code": "002030"
  },
  {
    "title": "达安基因：全资子公司抗原检测试剂盒获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/12114037205114.shtml",
    "datetime": "2022-12-12 11:40:27",
    "code": "002030"
  },
  {
    "title": "A股异动丨达安基因涨约4% 新冠抗原检测试剂盒获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/12094237204605.shtml",
    "datetime": "2022-12-12 09:42:35",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：新型冠状病毒(2019-nCoV)抗原检测试剂盒(胶体金法)获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/12075137204296.shtml",
    "datetime": "2022-12-12 07:51:07",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：安杰思首发股票并在科创板上市申请获上交所审核通过",
    "href": "http://stock.jrj.com.cn/2022/11/07204137118435.shtml",
    "datetime": "2022-11-07 20:41:51",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：CYP3A5基因分型检测试剂盒(PCR-荧光探针法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/11/04115237112224.shtml",
    "datetime": "2022-11-04 11:52:02",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：第三季度净利13.16亿元，同比增长42.04%",
    "href": "http://stock.jrj.com.cn/2022/10/28232137096231.shtml",
    "datetime": "2022-10-28 23:21:06",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：全资子公司收到现金分红款193.42万元",
    "href": "http://stock.jrj.com.cn/2022/10/26115237085006.shtml",
    "datetime": "2022-10-26 11:52:36",
    "code": "002030"
  },
  {
    "title": "A股异动 | 达安基因(002030.SZ)涨超4% 取得人巨细胞病毒核酸测定试剂盒(PCR-荧光探针法)医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/10/14132137055464.shtml",
    "datetime": "2022-10-14 13:21:58",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)取得1个医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/10/14114837055279.shtml",
    "datetime": "2022-10-14 11:48:16",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：单纯疱疹病毒Ⅱ型核酸检测试剂盒(PCR-荧光探针法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/09/22172437014538.shtml",
    "datetime": "2022-09-22 17:24:12",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)半年度净利润35.95亿元 同比增长124.96%",
    "href": "http://stock.jrj.com.cn/2022/08/29235736949860.shtml",
    "datetime": "2022-08-29 23:57:45",
    "code": "002030"
  },
  {
    "title": "达安基因：子公司取得三个医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/08/08171336879351.shtml",
    "datetime": "2022-08-08 17:13:48",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：子公司3项产品取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/08/08170536879329.shtml",
    "datetime": "2022-08-08 17:05:25",
    "code": "002030"
  },
  {
    "title": "达安基因2022年上半年净利35.57亿同比增长122.59% 海外市场开拓与布局加强",
    "href": "http://stock.jrj.com.cn/2022/07/28183236851230.shtml",
    "datetime": "2022-07-28 18:32:21",
    "code": "002030"
  },
  {
    "title": "达安基因业绩快报：上半年归母净利润约35.57亿元 同比增长122.59%",
    "href": "http://stock.jrj.com.cn/2022/07/28172536851002.shtml",
    "datetime": "2022-07-28 17:25:51",
    "code": "002030"
  },
  {
    "title": "达安基因：上半年净利润35.57亿元 同比增长122.59%",
    "href": "http://stock.jrj.com.cn/2022/07/28165736850701.shtml",
    "datetime": "2022-07-28 16:57:07",
    "code": "002030"
  },
  {
    "title": "达安基因业绩快报：上半年净利润35.57亿元 同比增长122.59%",
    "href": "http://stock.jrj.com.cn/2022/07/28162636850535.shtml",
    "datetime": "2022-07-28 16:26:08",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)业绩快报：半年度净利润35.57亿元、同比增长122.59%",
    "href": "http://stock.jrj.com.cn/2022/07/28161536850489.shtml",
    "datetime": "2022-07-28 16:15:48",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：人博卡病毒核酸检测试剂盒(PCR-荧光探针法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/07/22170336836121.shtml",
    "datetime": "2022-07-22 17:03:16",
    "code": "002030"
  },
  {
    "title": "达安基因22022年上半年预计净利33亿-37亿 同比增加107%-132% 市场对产品需求增加",
    "href": "http://stock.jrj.com.cn/2022/07/13191036808412.shtml",
    "datetime": "2022-07-13 19:10:47",
    "code": "002030"
  },
  {
    "title": "达安基因：预计上半年净利同比增107%-132%",
    "href": "http://stock.jrj.com.cn/2022/07/13170736807748.shtml",
    "datetime": "2022-07-13 17:07:05",
    "code": "002030"
  },
  {
    "title": "达安基因：本公司新冠核酸检测试剂盒可检测出BA.5毒株",
    "href": "http://stock.jrj.com.cn/2022/07/07195036792003.shtml",
    "datetime": "2022-07-07 19:50:04",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：达安科技收到参股公司现金分红款94.12万元",
    "href": "http://stock.jrj.com.cn/2022/07/07161236791036.shtml",
    "datetime": "2022-07-07 16:12:35",
    "code": "002030"
  },
  {
    "title": "达安基因总经理周新宇辞职 2021年薪酬为651.38万",
    "href": "http://stock.jrj.com.cn/2022/06/06215236707243.shtml",
    "datetime": "2022-06-06 21:52:10",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：周新宇辞任总经理",
    "href": "http://stock.jrj.com.cn/2022/06/06195536706876.shtml",
    "datetime": "2022-06-06 19:55:00",
    "code": "002030"
  },
  {
    "title": "达安基因管理层之变",
    "href": "http://stock.jrj.com.cn/2022/06/01152436696734.shtml",
    "datetime": "2022-06-01 15:24:01",
    "code": "002030"
  },
  {
    "title": "A股异动丨达安基因创逾四个月新高 猴痘病毒核酸检测试剂盒获得CE注册证书",
    "href": "http://stock.jrj.com.cn/2022/05/24103236672990.shtml",
    "datetime": "2022-05-24 10:32:59",
    "code": "002030"
  },
  {
    "title": "达安基因猴痘检测试剂盒获CE注册证书，国务院33项实招稳经济…重要消息还有这些",
    "href": "http://stock.jrj.com.cn/2022/05/24084636672613.shtml",
    "datetime": "2022-05-24 08:46:05",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：猴痘病毒核酸检测试剂盒(荧光PCR法)获得CE注册证书",
    "href": "http://stock.jrj.com.cn/2022/05/24081136672553.shtml",
    "datetime": "2022-05-24 08:11:20",
    "code": "002030"
  },
  {
    "title": "A股异动 | 生物疫苗概念股大幅高开 达安基因一字涨停",
    "href": "http://stock.jrj.com.cn/2022/05/23092936669121.shtml",
    "datetime": "2022-05-23 09:29:39",
    "code": "002030"
  },
  {
    "title": "孙公司即将登陆港交所 达安基因业绩飙升能否继续？",
    "href": "http://stock.jrj.com.cn/2022/05/19081336661085.shtml",
    "datetime": "2022-05-19 08:13:00",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：参股公司云康集团将于5月18日登陆港交所",
    "href": "http://stock.jrj.com.cn/2022/05/17172136655573.shtml",
    "datetime": "2022-05-17 17:21:10",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)近日取得1个医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/05/16163436651510.shtml",
    "datetime": "2022-05-16 16:34:30",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)一季度净利润16.80亿元 同比增长48.85%",
    "href": "http://stock.jrj.com.cn/2022/05/04202036559375.shtml",
    "datetime": "2022-05-04 20:20:07",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：董事会、监事会将延期换届选举",
    "href": "http://stock.jrj.com.cn/2022/04/15115536342539.shtml",
    "datetime": "2022-04-15 11:55:39",
    "code": "002030"
  },
  {
    "title": "达安基因2021年实现高质量发展：财务健康得到进一步巩固",
    "href": "http://stock.jrj.com.cn/2022/03/31111036232266.shtml",
    "datetime": "2022-03-31 11:10:40",
    "code": "002030"
  },
  {
    "title": "达安基因2021年净利36.18亿同比增长47.74% 董事长何蕴韶薪酬726.26万",
    "href": "http://stock.jrj.com.cn/2022/03/31095236229663.shtml",
    "datetime": "2022-03-31 09:52:52",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：2021年净利增47.74%至36.18亿元 拟10派11.1元",
    "href": "http://stock.jrj.com.cn/2022/03/30212536207111.shtml",
    "datetime": "2022-03-30 21:25:52",
    "code": "002030"
  },
  {
    "title": "达安基因股东周新宇减持95.28万股 套现1930万 2021年公司净利35.92亿",
    "href": "http://stock.jrj.com.cn/2022/02/28211234501940.shtml",
    "datetime": "2022-02-28 21:12:32",
    "code": "002030"
  },
  {
    "title": "达安基因：取得一项医疗器械注册证 拓宽公司产品应用领域",
    "href": "http://stock.jrj.com.cn/2022/02/28140134496522.shtml",
    "datetime": "2022-02-28 14:01:35",
    "code": "002030"
  },
  {
    "title": "达安基因2021年净利35.92亿同比增长46.67% 联营企业业绩增长",
    "href": "http://stock.jrj.com.cn/2022/02/25191234465641.shtml",
    "datetime": "2022-02-25 19:12:31",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：广州生物工程中心拟将5%的股份无偿划转至广州金控集团",
    "href": "http://stock.jrj.com.cn/2022/02/07200134302986.shtml",
    "datetime": "2022-02-07 20:01:44",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：生物工程中心拟继续参与转融通证券出借业务 出借数量不超1403.44万股",
    "href": "http://stock.jrj.com.cn/2022/01/06170734129944.shtml",
    "datetime": "2022-01-06 17:07:47",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)及全资子公司近日收到现金分红款989.57万元",
    "href": "http://stock.jrj.com.cn/2021/12/31173934093668.shtml",
    "datetime": "2021-12-31 17:39:56",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：人乳头瘤病毒(20个型)基因分型检测试剂盒(PCR-电化学基因芯片法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/12/20160434034594.shtml",
    "datetime": "2021-12-20 16:04:26",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：拟投资不超10亿元进行扩产项目",
    "href": "http://stock.jrj.com.cn/2021/12/13174334009299.shtml",
    "datetime": "2021-12-13 17:43:12",
    "code": "002030"
  },
  {
    "title": "达安基因拟与广州开发区投资促进局签订《达安基因扩产项目投资合作协议》",
    "href": "http://stock.jrj.com.cn/2021/12/13174134009284.shtml",
    "datetime": "2021-12-13 17:41:32",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：两名董事减持期过半 均尚未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/26161333923766.shtml",
    "datetime": "2021-11-26 16:13:11",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：子公司收到现金分红款3107.28万元",
    "href": "http://stock.jrj.com.cn/2021/11/04160633812913.shtml",
    "datetime": "2021-11-04 16:06:10",
    "code": "002030"
  },
  {
    "title": "达安基因：前三季度净利润25.25亿元，同比增长64.23%",
    "href": "http://stock.jrj.com.cn/2021/10/31141733784556.shtml",
    "datetime": "2021-10-31 14:17:06",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：第三季度净利升22.13%至9.27亿元",
    "href": "http://stock.jrj.com.cn/2021/10/29184833779035.shtml",
    "datetime": "2021-10-29 18:48:37",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：第三季度净利预增5.72%-45.26%",
    "href": "http://stock.jrj.com.cn/2021/10/13163933685164.shtml",
    "datetime": "2021-10-13 16:39:51",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：淋球菌核酸检测试剂盒(PCR-荧光探针法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/09/29155433536524.shtml",
    "datetime": "2021-09-29 15:54:11",
    "code": "002030"
  },
  {
    "title": "达安基因：参股公司安杰思科创板上市终止注册",
    "href": "http://stock.jrj.com.cn/2021/09/14064933432084.shtml",
    "datetime": "2021-09-14 06:49:00",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：参股公司安杰思科创板IPO终止注册",
    "href": "http://stock.jrj.com.cn/2021/09/13155333428456.shtml",
    "datetime": "2021-09-13 15:53:22",
    "code": "002030"
  },
  {
    "title": "达安基因2021年半年度净利15.98亿元 同比净利增加105.25%",
    "href": "http://stock.jrj.com.cn/2021/08/27183233334692.shtml",
    "datetime": "2021-08-27 18:32:43",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)上半年净利升105.25%至15.98亿元",
    "href": "http://stock.jrj.com.cn/2021/08/27182533334648.shtml",
    "datetime": "2021-08-27 18:25:41",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新冠核酸检测试剂盒可检测出拉姆达病毒变异株",
    "href": "http://stock.jrj.com.cn/2021/08/11133033236952.shtml",
    "datetime": "2021-08-11 13:30:44",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)取得两个医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/08/09162533225635.shtml",
    "datetime": "2021-08-09 16:25:25",
    "code": "002030"
  },
  {
    "title": "上半年净利润翻倍“难阻”达安基因董事长总经理再减持1000万股",
    "href": "http://stock.jrj.com.cn/2021/08/06085633211617.shtml",
    "datetime": "2021-08-06 08:56:00",
    "code": "002030"
  },
  {
    "title": "达安基因2名股东拟合计减持不超1077.09万股公司股份 上半年公司净利15.9亿",
    "href": "http://stock.jrj.com.cn/2021/08/04184833202578.shtml",
    "datetime": "2021-08-04 18:48:58",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：董事长何蕴韶和总经理周新宇拟合计减持不超1077.0937万股",
    "href": "http://stock.jrj.com.cn/2021/08/04164933201729.shtml",
    "datetime": "2021-08-04 16:49:57",
    "code": "002030"
  },
  {
    "title": "A股异动 | 达安基因(002030.SZ)涨超5% 上半年净利同比增长104.24%",
    "href": "http://stock.jrj.com.cn/2021/07/30102833174195.shtml",
    "datetime": "2021-07-30 10:28:01",
    "code": "002030"
  },
  {
    "title": "达安基因：上半年净利润15.9亿元 同比增长104%",
    "href": "http://stock.jrj.com.cn/2021/07/30065633173489.shtml",
    "datetime": "2021-07-30 06:56:00",
    "code": "002030"
  },
  {
    "title": "达安基因2021年上半年净利15.9亿增长104.24% 核酸检测仪器需求量增长",
    "href": "http://stock.jrj.com.cn/2021/07/29192033170755.shtml",
    "datetime": "2021-07-29 19:20:00",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)业绩快报：半年度净利润升104.24%至15.9亿元",
    "href": "http://stock.jrj.com.cn/2021/07/29162733169819.shtml",
    "datetime": "2021-07-29 16:27:13",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因7月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/28180633164818.shtml",
    "datetime": "2021-07-28 18:06:33",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：获得“解脲脲原体核酸检测试剂盒(PCR-荧光探针法)”的医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/07/28170533164453.shtml",
    "datetime": "2021-07-28 17:05:12",
    "code": "002030"
  },
  {
    "title": "涨停复盘：新馆检测概念崛起，达安基因等多股涨停，三胎概念盘中拉升掀涨停潮",
    "href": "http://stock.jrj.com.cn/2021/07/28153533164004.shtml",
    "datetime": "2021-07-28 15:35:44",
    "code": "002030"
  },
  {
    "title": "【盘中热讯】达安基因涨停！泰康医学、迪安诊断涨超12%，三孩概念、核酸检测等医疗板块全线拉升！",
    "href": "http://stock.jrj.com.cn/2021/07/28134533163554.shtml",
    "datetime": "2021-07-28 13:45:54",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：减持期均届满 董事何蕴韶和周新宇未减持股份",
    "href": "http://stock.jrj.com.cn/2021/07/27163633158506.shtml",
    "datetime": "2021-07-27 16:36:36",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：拟以3015.5万元购买上海物流中心用房",
    "href": "http://stock.jrj.com.cn/2021/07/20181833125216.shtml",
    "datetime": "2021-07-20 18:18:54",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：拟以2.1亿元认购达瑞生物增发的1518.44万股",
    "href": "http://stock.jrj.com.cn/2021/06/30210933023638.shtml",
    "datetime": "2021-06-30 21:09:59",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前经营情况正常",
    "href": "http://stock.jrj.com.cn/2021/06/23212732985202.shtml",
    "datetime": "2021-06-23 21:27:49",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前新冠核酸检测试剂日均标准产能约为100万人份/日以上",
    "href": "http://stock.jrj.com.cn/2021/06/23212732985191.shtml",
    "datetime": "2021-06-23 21:27:05",
    "code": "002030"
  },
  {
    "title": "达安基因：目前公司的科研生产大楼正在加紧施工建设当中",
    "href": "http://stock.jrj.com.cn/2021/06/23212732985188.shtml",
    "datetime": "2021-06-23 21:27:02",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：肺炎支原体核酸检测试剂盒(PCR-荧光探针法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/06/22114832975466.shtml",
    "datetime": "2021-06-22 11:48:42",
    "code": "002030"
  },
  {
    "title": "达安基因：公司主营产品为PCR诊断试剂及仪器",
    "href": "http://stock.jrj.com.cn/2021/06/15170932935191.shtml",
    "datetime": "2021-06-15 17:09:47",
    "code": "002030"
  },
  {
    "title": "达安基因：公司全资子公司广州市达安基因科技有限公司直接持有其11.3386%股份",
    "href": "http://stock.jrj.com.cn/2021/06/15170432935177.shtml",
    "datetime": "2021-06-15 17:04:41",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：广州生物工程中心拟参与转融通证券出借业务",
    "href": "http://stock.jrj.com.cn/2021/06/15013132929546.shtml",
    "datetime": "2021-06-15 01:31:09",
    "code": "002030"
  },
  {
    "title": "达安基因：公司已研发出新冠病毒变异株（B.1.167）核酸检测试剂盒",
    "href": "http://stock.jrj.com.cn/2021/06/11204632913816.shtml",
    "datetime": "2021-06-11 20:46:43",
    "code": "002030"
  },
  {
    "title": "达安基因：公司产品中包括EGFR基因突变检测试剂盒（PCR-测序法）、KRAS基因突变检测试剂盒（PCR-测序法）",
    "href": "http://stock.jrj.com.cn/2021/06/11193332913229.shtml",
    "datetime": "2021-06-11 19:33:28",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前新冠核酸检测试剂日均标准产能约为100万人份/日以上",
    "href": "http://stock.jrj.com.cn/2021/06/08172032894236.shtml",
    "datetime": "2021-06-08 17:20:39",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新型冠状病毒核酸检测相关产品已经发往了全球140多个国家和地区",
    "href": "http://stock.jrj.com.cn/2021/06/08070432890598.shtml",
    "datetime": "2021-06-08 07:04:09",
    "code": "002030"
  },
  {
    "title": "达安基因：公司将持续启动充足的产能提供新型冠状病毒核酸检测产品",
    "href": "http://stock.jrj.com.cn/2021/06/07215232889149.shtml",
    "datetime": "2021-06-07 21:52:12",
    "code": "002030"
  },
  {
    "title": "达安基因：检测服务相关业务主要由公司子公司云康健康产业投资股份有限公司运营",
    "href": "http://stock.jrj.com.cn/2021/06/07212632888965.shtml",
    "datetime": "2021-06-07 21:26:05",
    "code": "002030"
  },
  {
    "title": "达安基因：新生儿筛查及产前筛查业务主要由公司控股子公司广州市达瑞生物技术股份有限公司负责运营",
    "href": "http://stock.jrj.com.cn/2021/06/07190932888267.shtml",
    "datetime": "2021-06-07 19:09:25",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：公司名称已变更为“广州达安基因股份有限公司”",
    "href": "http://stock.jrj.com.cn/2021/06/03155332869321.shtml",
    "datetime": "2021-06-03 15:53:21",
    "code": "002030"
  },
  {
    "title": "达安基因：辅助生殖领域相关业务主要由公司参股公司苏州贝康医疗股份有限公司运营",
    "href": "http://stock.jrj.com.cn/2021/06/02172832864027.shtml",
    "datetime": "2021-06-02 17:28:27",
    "code": "002030"
  },
  {
    "title": "达安基因：公司正积极开展海外市场相关工作",
    "href": "http://stock.jrj.com.cn/2021/06/01183532858323.shtml",
    "datetime": "2021-06-01 18:35:05",
    "code": "002030"
  },
  {
    "title": "达安基因：公司与华为暂无关联关系",
    "href": "http://stock.jrj.com.cn/2021/06/01183032858300.shtml",
    "datetime": "2021-06-01 18:30:14",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新冠核酸检测试剂盒有提供给包括广州和中山在内的全国多省市和地区",
    "href": "http://stock.jrj.com.cn/2021/06/01182832858270.shtml",
    "datetime": "2021-06-01 18:28:12",
    "code": "002030"
  },
  {
    "title": "达安基因：公司暂无疫苗研发业务",
    "href": "http://stock.jrj.com.cn/2021/06/01182732858267.shtml",
    "datetime": "2021-06-01 18:27:31",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新冠核酸检测试剂盒有提供给包括广东省在内的全国多省市和地区",
    "href": "http://stock.jrj.com.cn/2021/05/27172932830645.shtml",
    "datetime": "2021-05-27 17:29:32",
    "code": "002030"
  },
  {
    "title": "达安基因：新冠抗体检测主要由达安子公司中山生物和达瑞生物进行开发",
    "href": "http://stock.jrj.com.cn/2021/05/27172232830601.shtml",
    "datetime": "2021-05-27 17:22:16",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：授权管理层处置Yunkang Group Limited部分股权",
    "href": "http://stock.jrj.com.cn/2021/05/17223732771883.shtml",
    "datetime": "2021-05-17 22:37:35",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：已收到达瑞生物的分红款约1005.11万元",
    "href": "http://stock.jrj.com.cn/2021/05/13171732749039.shtml",
    "datetime": "2021-05-13 17:17:32",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新型冠状病毒核酸检测相关产品已经发往了全球140多个国家和地区",
    "href": "http://stock.jrj.com.cn/2021/05/13163932748758.shtml",
    "datetime": "2021-05-13 16:39:14",
    "code": "002030"
  },
  {
    "title": "达安基因：公司在派发股息红利时暂不扣缴所得税",
    "href": "http://stock.jrj.com.cn/2021/05/13163632748739.shtml",
    "datetime": "2021-05-13 16:36:39",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因5月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/12180532743116.shtml",
    "datetime": "2021-05-12 18:05:10",
    "code": "002030"
  },
  {
    "title": "战“疫”牛股达安基因涨停，正海生物涨超8%，抗疫医疗、医美概念持续走强！",
    "href": "http://stock.jrj.com.cn/2021/05/12135032741603.shtml",
    "datetime": "2021-05-12 13:50:33",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)2020年度权益分派10送6派5.5元 股权登记日为5月18日",
    "href": "http://stock.jrj.com.cn/2021/05/11175732736312.shtml",
    "datetime": "2021-05-11 17:57:35",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)一季度净利大增505.59%至11.29亿元",
    "href": "http://stock.jrj.com.cn/2021/04/28173732472606.shtml",
    "datetime": "2021-04-28 17:37:23",
    "code": "002030"
  },
  {
    "title": "达安基因：公司辅助生殖领域相关业务主要由公司参股公司苏州贝康医疗股份有限公司运营",
    "href": "http://stock.jrj.com.cn/2021/04/28171732472466.shtml",
    "datetime": "2021-04-28 17:17:11",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前新冠核酸检测试剂日均标准产能约为100万人份/日左右",
    "href": "http://stock.jrj.com.cn/2021/04/28090232469107.shtml",
    "datetime": "2021-04-28 09:02:09",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前新冠核酸耗材日均标准产能约为100万人份/日左右",
    "href": "http://stock.jrj.com.cn/2021/04/27170832463745.shtml",
    "datetime": "2021-04-27 17:08:53",
    "code": "002030"
  },
  {
    "title": "达安基因：公司暂无新冠病毒自检产品",
    "href": "http://stock.jrj.com.cn/2021/04/19162232402303.shtml",
    "datetime": "2021-04-19 16:22:06",
    "code": "002030"
  },
  {
    "title": "达安基因全力保供一季度预盈12亿 核酸检测产品助力全球抗疫",
    "href": "http://stock.jrj.com.cn/2021/04/15071732376627.shtml",
    "datetime": "2021-04-15 07:17:43",
    "code": "002030"
  },
  {
    "title": "1季度盈利暴涨5倍，达安基因涨超6%！医疗龙头股攻势强劲",
    "href": "http://stock.jrj.com.cn/2021/04/14105732370077.shtml",
    "datetime": "2021-04-14 10:57:14",
    "code": "002030"
  },
  {
    "title": "A股异动 | 达安基因(002030.SZ)涨逾4% 预计一季度盈利同比增长436.57%-543.89%",
    "href": "http://stock.jrj.com.cn/2021/04/14093332369391.shtml",
    "datetime": "2021-04-14 09:33:40",
    "code": "002030"
  },
  {
    "title": "达安基因2021年第一季度预计净利增长437%-544% 核酸检测仪相关耗材需求增长",
    "href": "http://stock.jrj.com.cn/2021/04/13183832366290.shtml",
    "datetime": "2021-04-13 18:38:50",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)一季度预盈10亿-12亿元 同比增长436.57%-543.89%",
    "href": "http://stock.jrj.com.cn/2021/04/13162532365344.shtml",
    "datetime": "2021-04-13 16:25:13",
    "code": "002030"
  },
  {
    "title": "达安基因：预计第一季度净利润同比增长436.57%-543.89%",
    "href": "http://stock.jrj.com.cn/2021/04/13160632365075.shtml",
    "datetime": "2021-04-13 16:06:40",
    "code": "002030"
  },
  {
    "title": "达安基因：双方将就互联网疾病检测、互联网疾病管理等多方面开展全面合作",
    "href": "http://stock.jrj.com.cn/2021/04/07164332325660.shtml",
    "datetime": "2021-04-07 16:43:52",
    "code": "002030"
  },
  {
    "title": "达安基因：公司未来将积极推进三个总体策略的实施",
    "href": "http://stock.jrj.com.cn/2021/04/07163732325615.shtml",
    "datetime": "2021-04-07 16:37:13",
    "code": "002030"
  },
  {
    "title": "达安基因：公司子公司目前有结合互联网提供疾病检测方面的业务",
    "href": "http://stock.jrj.com.cn/2021/04/07163132325565.shtml",
    "datetime": "2021-04-07 16:31:06",
    "code": "002030"
  },
  {
    "title": "A股异动 | 达安基因(002030.SZ)涨6.69% 2020年度净利润暴增2556.8%",
    "href": "http://stock.jrj.com.cn/2021/03/31105632254434.shtml",
    "datetime": "2021-03-31 10:56:00",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：中文名称拟变更为“达安基因股份有限公司”",
    "href": "http://stock.jrj.com.cn/2021/03/30225432250803.shtml",
    "datetime": "2021-03-30 22:54:46",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)2020年度净利润升2556.8%至24.49亿元 拟10送6派5.5元",
    "href": "http://stock.jrj.com.cn/2021/03/30225332250798.shtml",
    "datetime": "2021-03-30 22:53:41",
    "code": "002030"
  },
  {
    "title": "达安基因：目前公司新冠核酸检测试剂等产品销售仍以国内市场为主",
    "href": "http://stock.jrj.com.cn/2021/03/22111432191471.shtml",
    "datetime": "2021-03-22 11:14:08",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：润虹医药拟向全国股转系统申请终止挂牌",
    "href": "http://stock.jrj.com.cn/2021/03/19164032164476.shtml",
    "datetime": "2021-03-19 16:40:20",
    "code": "002030"
  },
  {
    "title": "达安基因参股孙公司云康开曼向港交所提交上市申请",
    "href": "http://stock.jrj.com.cn/2021/03/01094232048141.shtml",
    "datetime": "2021-03-01 09:42:00",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：参股孙公司云康开曼向港交所递表",
    "href": "http://stock.jrj.com.cn/2021/03/01082432047763.shtml",
    "datetime": "2021-03-01 08:24:00",
    "code": "002030"
  },
  {
    "title": "易瑞生物：公司与华大基因、达安基因等公司不存在同业竞争的情形",
    "href": "http://stock.jrj.com.cn/2021/02/26190332034618.shtml",
    "datetime": "2021-02-26 19:03:44",
    "code": "002030"
  },
  {
    "title": "核算检测耗材需求量大增，达安基因2020年盈利同比增长25倍",
    "href": "http://stock.jrj.com.cn/2021/02/26104032031710.shtml",
    "datetime": "2021-02-26 10:40:29",
    "code": "002030"
  },
  {
    "title": "2020年净利暴增2539.66% 达安基因(002030.SZ)逼近涨停",
    "href": "http://stock.jrj.com.cn/2021/02/26102232031534.shtml",
    "datetime": "2021-02-26 10:22:48",
    "code": "002030"
  },
  {
    "title": "达安基因2020年度净利24亿增长2540% 联营企业业绩增长",
    "href": "http://stock.jrj.com.cn/2021/02/26101032031464.shtml",
    "datetime": "2021-02-26 10:10:19",
    "code": "002030"
  },
  {
    "title": "检测试剂行业景气爆棚 圣湘生物净利大增65倍",
    "href": "http://stock.jrj.com.cn/2021/02/26032132029037.shtml",
    "datetime": "2021-02-26 03:21:15",
    "code": "002030"
  },
  {
    "title": "达安基因业绩快报：2020年度净利润24.33亿元 同比增长2540%",
    "href": "http://stock.jrj.com.cn/2021/02/25161632025787.shtml",
    "datetime": "2021-02-25 16:16:09",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)业绩快报：2020年度净利润升2539.66%至24.33亿元",
    "href": "http://stock.jrj.com.cn/2021/02/25161632025806.shtml",
    "datetime": "2021-02-25 16:16:06",
    "code": "002030"
  },
  {
    "title": "达安基因业绩快报：2020年度净利润24.33亿元 同比增长2540%",
    "href": "http://stock.jrj.com.cn/2021/02/25161632025782.shtml",
    "datetime": "2021-02-25 16:16:01",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：参股公司贝康医疗在联交所挂牌上市",
    "href": "http://stock.jrj.com.cn/2021/02/08161931870460.shtml",
    "datetime": "2021-02-08 16:19:18",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：糖类抗原19-9测定试剂盒(化学发光免疫分析法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/02/08161731870452.shtml",
    "datetime": "2021-02-08 16:17:17",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：拟向招商银行广州分行申请1亿元综合授信额度",
    "href": "http://stock.jrj.com.cn/2021/02/07182831861585.shtml",
    "datetime": "2021-02-07 18:28:53",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前新冠核酸检测试剂日均试剂盒标准产能约为150万人份/日以上",
    "href": "http://stock.jrj.com.cn/2021/02/04104431847490.shtml",
    "datetime": "2021-02-04 10:44:16",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因1月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/22180631746286.shtml",
    "datetime": "2021-01-22 18:06:34",
    "code": "002030"
  },
  {
    "title": "达安基因：公司业务范围涵盖了以分子诊断技术、免疫诊断技术、生化诊断技术、POCT等",
    "href": "http://stock.jrj.com.cn/2021/01/13160131684191.shtml",
    "datetime": "2021-01-13 16:01:03",
    "code": "002030"
  },
  {
    "title": "达安基因：公司正持续开展海外市场相关工作 旗下新冠检测试剂盒有出口到欧美国家",
    "href": "http://stock.jrj.com.cn/2021/01/06112231640515.shtml",
    "datetime": "2021-01-06 11:22:59",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：董事长及总经理拟合计减持不超673.1836万股",
    "href": "http://stock.jrj.com.cn/2021/01/05172031635084.shtml",
    "datetime": "2021-01-05 17:20:20",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)下属子公司取得一个医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/12/30212131607016.shtml",
    "datetime": "2020-12-30 21:21:41",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新冠核酸检测试剂适用于检测变异后的新冠病毒",
    "href": "http://stock.jrj.com.cn/2020/12/25143931569762.shtml",
    "datetime": "2020-12-25 14:39:10",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：第二大股东无偿划转股份完成过户登记",
    "href": "http://stock.jrj.com.cn/2020/12/24114631560420.shtml",
    "datetime": "2020-12-24 11:46:05",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因12月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/12/22180431546371.shtml",
    "datetime": "2020-12-22 18:04:53",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：公司实控人由“中山大学”变更为“广州市人民政府”",
    "href": "http://stock.jrj.com.cn/2020/12/21174631537324.shtml",
    "datetime": "2020-12-21 17:46:40",
    "code": "002030"
  },
  {
    "title": "达安基因(002030.SZ)：第二大股东无偿划转股份过户材料已通过深交所审核",
    "href": "http://stock.jrj.com.cn/2020/12/14123531485874.shtml",
    "datetime": "2020-12-14 12:35:05",
    "code": "002030"
  },
  {
    "title": "达安基因股东周新宇减持77.23万股 套现约2514.76万元",
    "href": "http://stock.jrj.com.cn/2020/11/30191931377689.shtml",
    "datetime": "2020-11-30 19:19:43",
    "code": "002030"
  },
  {
    "title": "达安基因：公司未来将聚焦于临床诊断技术与产品",
    "href": "http://stock.jrj.com.cn/2020/11/25154331346110.shtml",
    "datetime": "2020-11-25 15:43:38",
    "code": "002030"
  },
  {
    "title": "达安基因：公司未来将持续聚焦于临床诊断技术与产品",
    "href": "http://stock.jrj.com.cn/2020/11/10104631249392.shtml",
    "datetime": "2020-11-10 10:46:17",
    "code": "002030"
  },
  {
    "title": "达安基因参股公司安杰思科创板上市申请获通过 远大医药新冠DNA疫苗在美获批启动I期临床试验 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/11/04182531215664.shtml",
    "datetime": "2020-11-04 18:25:58",
    "code": "002030"
  },
  {
    "title": "达安基因2020年前三季度净利15.37亿增长1817.41% 联营企业业绩增加",
    "href": "http://stock.jrj.com.cn/2020/11/01151531183932.shtml",
    "datetime": "2020-11-01 15:15:26",
    "code": "002030"
  },
  {
    "title": "达安基因：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/30231031177501.shtml",
    "datetime": "2020-10-30 23:10:00",
    "code": "002030"
  },
  {
    "title": "A股异动 | 达安基因(002030.SZ)一度触及涨停 新冠试剂盒已获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/10/12144831032090.shtml",
    "datetime": "2020-10-12 14:48:23",
    "code": "002030"
  },
  {
    "title": "大洋医疗违法生产不合规器械遭罚 为达安基因子公司",
    "href": "http://stock.jrj.com.cn/2020/09/17174530770673.shtml",
    "datetime": "2020-09-17 17:45:00",
    "code": "002030"
  },
  {
    "title": "康龙化成拟投资35亿元建设生物医药基地项目 达安基因上半年归母净利润增长超10倍 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/31185130644859.shtml",
    "datetime": "2020-08-31 18:51:09",
    "code": "002030"
  },
  {
    "title": "达安基因2020年上半年净利7.78亿增长1186% 相关耗材需求量大幅度增长",
    "href": "http://stock.jrj.com.cn/2020/08/30153130622649.shtml",
    "datetime": "2020-08-30 15:31:09",
    "code": "002030"
  },
  {
    "title": "达安基因：上半年净利同比增长1186.48%",
    "href": "http://stock.jrj.com.cn/2020/08/28214230616816.shtml",
    "datetime": "2020-08-28 21:42:00",
    "code": "002030"
  },
  {
    "title": "达安基因：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/28210030616616.shtml",
    "datetime": "2020-08-28 21:00:00",
    "code": "002030"
  },
  {
    "title": "达安基因上半年净利润同比增长超11倍",
    "href": "http://stock.jrj.com.cn/2020/08/28204830616534.shtml",
    "datetime": "2020-08-28 20:48:58",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新冠病毒核酸检测相关产品已发往全球140多个国家和地区",
    "href": "http://stock.jrj.com.cn/2020/08/25114130584302.shtml",
    "datetime": "2020-08-25 11:41:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]安必平股份(688393)今日在上交所上市",
    "href": "http://stock.jrj.com.cn/2020/08/20000031492877.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]测核酸,广州又有“硬核”科研成果!新试剂30分钟出结果",
    "href": "http://stock.jrj.com.cn/2020/08/20000031492878.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]VLOG大赛 核酸检测试剂盒的全球旅行",
    "href": "http://stock.jrj.com.cn/2020/08/20000031492872.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "002030"
  },
  {
    "title": "达安基因：新冠核酸检测试剂盒产能可达100万人份/日以上 快速检测产品处于研发申报中",
    "href": "http://stock.jrj.com.cn/2020/08/17114030516724.shtml",
    "datetime": "2020-08-17 11:40:48",
    "code": "002030"
  },
  {
    "title": "达安基因：公司有少量核酸检测仪器出口",
    "href": "http://stock.jrj.com.cn/2020/08/10110930464360.shtml",
    "datetime": "2020-08-10 11:09:02",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因8月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/04180530425049.shtml",
    "datetime": "2020-08-04 18:05:44",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因8月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/03180630414396.shtml",
    "datetime": "2020-08-03 18:06:43",
    "code": "002030"
  },
  {
    "title": "达安基因第二大股东将变更为广州生物工程中心有限公司",
    "href": "http://stock.jrj.com.cn/2020/07/31210130396091.shtml",
    "datetime": "2020-07-31 21:01:02",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因7月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/30180730386357.shtml",
    "datetime": "2020-07-30 18:07:32",
    "code": "002030"
  },
  {
    "title": "上半年净利润同比增长1159.13% 达安基因盘中强势涨停",
    "href": "http://stock.jrj.com.cn/2020/07/30112130383488.shtml",
    "datetime": "2020-07-30 11:21:50",
    "code": "002030"
  },
  {
    "title": "达安基因净利润同比增加11倍 股价强势涨停创五年新高",
    "href": "http://stock.jrj.com.cn/2020/07/30112130383485.shtml",
    "datetime": "2020-07-30 11:21:07",
    "code": "002030"
  },
  {
    "title": "达安基因2020年上半年净利7.62亿增长1159.13% 核酸检测相关耗材需求量大幅增长",
    "href": "http://stock.jrj.com.cn/2020/07/29185830375043.shtml",
    "datetime": "2020-07-29 18:58:41",
    "code": "002030"
  },
  {
    "title": "达安基因：上半年净利润7.62亿元 同比增长11倍",
    "href": "http://stock.jrj.com.cn/2020/07/29171630374368.shtml",
    "datetime": "2020-07-29 17:16:20",
    "code": "002030"
  },
  {
    "title": "达安基因业绩快报：上半年净利润预增1159.13%",
    "href": "http://stock.jrj.com.cn/2020/07/29170430374312.shtml",
    "datetime": "2020-07-29 17:04:25",
    "code": "002030"
  },
  {
    "title": "[互动]达安基因 ：新冠病毒核酸检测相关产品已发往全球140多个国家和地区",
    "href": "http://stock.jrj.com.cn/2020/07/28110930361771.shtml",
    "datetime": "2020-07-28 11:09:05",
    "code": "002030"
  },
  {
    "title": "多家防疫用品公司中报业绩大增 达安基因上半年净利预增12倍",
    "href": "http://stock.jrj.com.cn/2020/07/15075830246427.shtml",
    "datetime": "2020-07-15 07:58:35",
    "code": "002030"
  },
  {
    "title": "达安基因：2020年半年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/07/13175030226671.shtml",
    "datetime": "2020-07-13 17:50:00",
    "code": "002030"
  },
  {
    "title": "达安基因上修业绩预期：预计上半年净利润同比增9到12倍 此前预增4到6倍",
    "href": "http://stock.jrj.com.cn/2020/07/13163330225706.shtml",
    "datetime": "2020-07-13 16:33:13",
    "code": "002030"
  },
  {
    "title": "达安基因上修业绩预期：预计上半年净利润同比增9到12倍",
    "href": "http://stock.jrj.com.cn/2020/07/13161530225580.shtml",
    "datetime": "2020-07-13 16:15:02",
    "code": "002030"
  },
  {
    "title": "【龙虎榜】达安基因7月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/10180630206526.shtml",
    "datetime": "2020-07-10 18:06:51",
    "code": "002030"
  },
  {
    "title": "快讯：达安基因急速拉升7.83% 主力资金净流入6592.96万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/03104730131825.shtml",
    "datetime": "2020-07-03 10:47:00",
    "code": "002030"
  },
  {
    "title": "校企改革获进展 达安基因实控人将变更",
    "href": "http://stock.jrj.com.cn/2020/07/03072530129413.shtml",
    "datetime": "2020-07-03 07:25:23",
    "code": "002030"
  },
  {
    "title": "达安基因实控人拟变更为广州市人民政府",
    "href": "http://stock.jrj.com.cn/2020/07/02184630124454.shtml",
    "datetime": "2020-07-02 18:46:29",
    "code": "002030"
  },
  {
    "title": "【公告抢先看】晚间重要公告：达安基因实控人拟发生变更、*ST中天三股东拟增持5000万股-1亿股公司股份……",
    "href": "http://stock.jrj.com.cn/2020/07/02184230124394.shtml",
    "datetime": "2020-07-02 18:42:49",
    "code": "002030"
  },
  {
    "title": "达安基因：公司实控人拟发生变更",
    "href": "http://stock.jrj.com.cn/2020/07/02181730124242.shtml",
    "datetime": "2020-07-02 18:17:22",
    "code": "002030"
  },
  {
    "title": "达安基因：公司业务目前主要集中在诊断领域 暂未涉及肿瘤治疗",
    "href": "http://stock.jrj.com.cn/2020/06/28164030068958.shtml",
    "datetime": "2020-06-28 16:40:10",
    "code": "002030"
  },
  {
    "title": "需求增加 半数核酸检测股股价创新高",
    "href": "http://stock.jrj.com.cn/2020/06/18021329952776.shtml",
    "datetime": "2020-06-18 02:13:39",
    "code": "002030"
  },
  {
    "title": "多家公司披露抗疫产品生产经营情况 达安基因核酸检测产品对业绩影响积极",
    "href": "http://stock.jrj.com.cn/2020/06/17225829951934.shtml",
    "datetime": "2020-06-17 22:58:17",
    "code": "002030"
  },
  {
    "title": "【公告解读】达安基因：核酸检测试剂盒等耗材的需求量大幅度增长",
    "href": "http://stock.jrj.com.cn/2020/06/17214229951623.shtml",
    "datetime": "2020-06-17 21:42:50",
    "code": "002030"
  },
  {
    "title": "达安基因：核酸检测对业绩影响的持续性尚无法估计",
    "href": "http://stock.jrj.com.cn/2020/06/17162129949682.shtml",
    "datetime": "2020-06-17 16:21:21",
    "code": "002030"
  },
  {
    "title": "达安基因爆炒之后显露疲态：新冠检测试剂产能难回峰值",
    "href": "http://stock.jrj.com.cn/2020/05/09083829623951.shtml",
    "datetime": "2020-05-09 08:38:50",
    "code": "002030"
  },
  {
    "title": "高管“精准”减持600万股 达安基因“坐拥”百亿市场 净利润却一降再降",
    "href": "http://stock.jrj.com.cn/2020/05/08084629616381.shtml",
    "datetime": "2020-05-08 08:46:00",
    "code": "002030"
  },
  {
    "title": "95家公司上半年业绩预喜 多行业亮点呈现",
    "href": "http://stock.jrj.com.cn/2020/05/08022729613800.shtml",
    "datetime": "2020-05-08 02:27:05",
    "code": "002030"
  },
  {
    "title": "达安基因2名股东拟减持股份 预计合计减持不超总股本0.79%",
    "href": "http://stock.jrj.com.cn/2020/05/07202629612337.shtml",
    "datetime": "2020-05-07 20:26:01",
    "code": "002030"
  },
  {
    "title": "达安基因2019年净利9218.18万下滑9.25% 董事长薪酬71.5万",
    "href": "http://stock.jrj.com.cn/2020/05/03155329499047.shtml",
    "datetime": "2020-05-03 15:53:42",
    "code": "002030"
  },
  {
    "title": "达安基因2020年一季度净利1.86亿增长559.37% 新冠试剂盒销售额增加较大所致",
    "href": "http://stock.jrj.com.cn/2020/05/01190329440963.shtml",
    "datetime": "2020-05-01 19:03:18",
    "code": "002030"
  },
  {
    "title": "大规模核酸检测来袭 达安基因等11股大涨",
    "href": "http://stock.jrj.com.cn/2020/04/24012829362105.shtml",
    "datetime": "2020-04-24 01:28:08",
    "code": "002030"
  },
  {
    "title": "达安基因四天三板市值逾200亿 一季度净利预增5至6倍",
    "href": "http://stock.jrj.com.cn/2020/04/22075529344958.shtml",
    "datetime": "2020-04-22 07:55:24",
    "code": "002030"
  },
  {
    "title": "龙虎榜：达安基因巨量成交超60亿元 深股通席位净卖出",
    "href": "http://stock.jrj.com.cn/2020/04/21174929339676.shtml",
    "datetime": "2020-04-21 17:49:00",
    "code": "002030"
  },
  {
    "title": "[互动]达安基因：已生产新冠检测试剂盒超过一千万人份",
    "href": "http://stock.jrj.com.cn/2020/04/21140929338256.shtml",
    "datetime": "2020-04-21 14:09:49",
    "code": "002030"
  },
  {
    "title": "多家公司检测试剂盒获美紧急使用授权",
    "href": "http://stock.jrj.com.cn/2020/04/21053829333245.shtml",
    "datetime": "2020-04-21 05:38:06",
    "code": "002030"
  },
  {
    "title": "体外诊断概念走强 达安基因等涨停",
    "href": "http://stock.jrj.com.cn/2020/04/20095629327487.shtml",
    "datetime": "2020-04-20 09:56:00",
    "code": "002030"
  },
  {
    "title": "检测试剂概念走强 达安基因等4股涨停",
    "href": "http://stock.jrj.com.cn/2020/04/20094329327085.shtml",
    "datetime": "2020-04-20 09:43:21",
    "code": "002030"
  },
  {
    "title": "检测试剂概念爆发 达安基因等7股涨停",
    "href": "http://stock.jrj.com.cn/2020/04/16131829303864.shtml",
    "datetime": "2020-04-16 13:18:40",
    "code": "002030"
  },
  {
    "title": "达安基因2019年度盈利9571万减少6% 部分子公司业绩下降",
    "href": "http://stock.jrj.com.cn/2020/04/15172729297154.shtml",
    "datetime": "2020-04-15 17:27:03",
    "code": "002030"
  },
  {
    "title": "达安基因：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292285.shtml",
    "datetime": "2020-04-15 08:00:12",
    "code": "002030"
  },
  {
    "title": "达安基因2020年一季度盈利为1.86亿元到2亿元核酸检测仪器需求量大幅增长",
    "href": "http://stock.jrj.com.cn/2020/04/14202329285951.shtml",
    "datetime": "2020-04-14 20:23:24",
    "code": "002030"
  },
  {
    "title": "达安基因：一季度净利预增5-6倍 核酸检测试剂盒等需求大幅增长",
    "href": "http://stock.jrj.com.cn/2020/04/14174929285019.shtml",
    "datetime": "2020-04-14 17:49:00",
    "code": "002030"
  },
  {
    "title": "[互动]达安基因：新冠核酸检测试剂盒产品累计供应超过五百万人份",
    "href": "http://stock.jrj.com.cn/2020/03/19144429060837.shtml",
    "datetime": "2020-03-19 14:44:58",
    "code": "002030"
  },
  {
    "title": "达安基因获得\"新型冠状病毒核酸检测试剂盒\"的医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/03/13165929020781.shtml",
    "datetime": "2020-03-13 16:59:03",
    "code": "002030"
  },
  {
    "title": "达安基因：已获得“新型冠状病毒核酸检测试剂盒”注册证",
    "href": "http://stock.jrj.com.cn/2020/03/13165229020754.shtml",
    "datetime": "2020-03-13 16:52:39",
    "code": "002030"
  },
  {
    "title": "达安基因：新型冠状病毒核酸检测试剂盒已获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/03/03105928943126.shtml",
    "datetime": "2020-03-03 10:59:00",
    "code": "002030"
  },
  {
    "title": "达安基因助力抗疫 及时推出核酸检测试剂",
    "href": "http://stock.jrj.com.cn/2020/02/13011828818363.shtml",
    "datetime": "2020-02-13 01:18:28",
    "code": "002030"
  },
  {
    "title": "达安基因：春节期间未停工 检测试剂盒日产能逐步提升",
    "href": "http://stock.jrj.com.cn/2020/02/12143828815390.shtml",
    "datetime": "2020-02-12 14:38:00",
    "code": "002030"
  },
  {
    "title": "达安基因：核酸检测结果的准确率可以保证",
    "href": "http://stock.jrj.com.cn/2020/02/12143328815321.shtml",
    "datetime": "2020-02-12 14:33:00",
    "code": "002030"
  },
  {
    "title": "达安基因：公司的检测试剂盒可同时检测两个基因靶位 能避免假阴性情况",
    "href": "http://stock.jrj.com.cn/2020/02/12143328815320.shtml",
    "datetime": "2020-02-12 14:33:00",
    "code": "002030"
  },
  {
    "title": "达安基因：最高1天可产出约100万人份的新型冠状病毒核酸检测试剂盒",
    "href": "http://stock.jrj.com.cn/2020/02/12142428815277.shtml",
    "datetime": "2020-02-12 14:24:24",
    "code": "002030"
  },
  {
    "title": "达安基因：公司新型冠状病毒核酸检测试剂盒的日产能大概是30万-50万人份左右",
    "href": "http://stock.jrj.com.cn/2020/02/12142428815279.shtml",
    "datetime": "2020-02-12 14:24:00",
    "code": "002030"
  },
  {
    "title": "达安基因：第一时间推出核酸检测试剂 科技助力“抗疫”战场",
    "href": "http://stock.jrj.com.cn/2020/02/12142128815243.shtml",
    "datetime": "2020-02-12 14:21:27",
    "code": "002030"
  },
  {
    "title": "【e公司微访谈】达安基因：第一时间推出核酸检测试剂 科技助力“抗疫”战场",
    "href": "http://stock.jrj.com.cn/2020/02/12140628815177.shtml",
    "datetime": "2020-02-12 14:06:00",
    "code": "002030"
  },
  {
    "title": "达安基因：试剂盒对公司业绩的影响目前尚无法估计",
    "href": "http://stock.jrj.com.cn/2020/02/10172828803797.shtml",
    "datetime": "2020-02-10 17:28:11",
    "code": "002030"
  },
  {
    "title": "达安基因：暂未涉及新冠肺炎疫苗研制和生产业务",
    "href": "http://stock.jrj.com.cn/2020/02/06140028783498.shtml",
    "datetime": "2020-02-06 14:00:00",
    "code": "002030"
  },
  {
    "title": "达安基因：试剂盒对公司业绩的影响目前尚无法估计",
    "href": "http://stock.jrj.com.cn/2020/02/04171228767819.shtml",
    "datetime": "2020-02-04 17:12:27",
    "code": "002030"
  },
  {
    "title": "达安基因：新型冠状病毒核酸检测试剂盒对公司业绩的影响尚无法估计",
    "href": "http://stock.jrj.com.cn/2020/02/04164728767683.shtml",
    "datetime": "2020-02-04 16:47:00",
    "code": "002030"
  },
  {
    "title": "达安基因：获得“新型冠状病毒（2019-nCoV)核酸检测试剂盒（荧光 PCR",
    "href": "http://stock.jrj.com.cn/2020/02/02173728748817.shtml",
    "datetime": "2020-02-02 17:37:52",
    "code": "002030"
  },
  {
    "title": "达安基因：已获得“新型冠状病毒（2019-nCoV)核酸检测试剂盒（荧光 PCR",
    "href": "http://stock.jrj.com.cn/2020/02/02173528748812.shtml",
    "datetime": "2020-02-02 17:35:00",
    "code": "002030"
  },
  {
    "title": "达安基因：取得新型冠状病毒核酸检测试剂盒的医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/02/02173028748796.shtml",
    "datetime": "2020-02-02 17:30:40",
    "code": "002030"
  },
  {
    "title": "医疗器械概念股午后拉升 振德医疗、达安基因等涨停",
    "href": "http://stock.jrj.com.cn/2020/01/20130928705371.shtml",
    "datetime": "2020-01-20 13:09:00",
    "code": "002030"
  },
  {
    "title": "达安基因：已针对新型冠状病毒研发出核酸试剂盒 尚未拿到正式注册资质",
    "href": "http://stock.jrj.com.cn/2020/01/20114028705113.shtml",
    "datetime": "2020-01-20 11:40:40",
    "code": "002030"
  },
  {
    "title": "达安基因：已针对新型冠状病毒研发出核酸试剂盒",
    "href": "http://stock.jrj.com.cn/2020/01/20113128705093.shtml",
    "datetime": "2020-01-20 11:31:05",
    "code": "002030"
  },
  {
    "title": "达安基因：下属子公司取得一个医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2019/12/18221528552853.shtml",
    "datetime": "2019-12-18 22:15:30",
    "code": "002030"
  },
  {
    "title": "达安基因：参股孙公司四方传媒新三板摘牌",
    "href": "http://stock.jrj.com.cn/2019/11/05180128355129.shtml",
    "datetime": "2019-11-05 18:01:12",
    "code": "002030"
  },
  {
    "title": "达安基因前三季度盈利8017万元 同比增长2.18%",
    "href": "http://stock.jrj.com.cn/2019/10/31204228335087.shtml",
    "datetime": "2019-10-31 20:42:42",
    "code": "002030"
  },
  {
    "title": "午间公告：达安基因实控人可能发生变更",
    "href": "http://stock.jrj.com.cn/2019/10/11115928232509.shtml",
    "datetime": "2019-10-11 11:59:08",
    "code": "002030"
  },
  {
    "title": "午间公告：达安基因实控人可能发生变更；招商蛇口前三季度净利预增136%-203",
    "href": "http://stock.jrj.com.cn/2019/10/11115928232533.shtml",
    "datetime": "2019-10-11 11:59:00",
    "code": "002030"
  },
  {
    "title": "【达安基因】大幅拉升1.45% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/16095528133479.shtml",
    "datetime": "2019-09-16 09:55:18",
    "code": "002030"
  },
  {
    "title": "达安基因：参股子公司腾飞基因获批新三板终止挂牌",
    "href": "http://stock.jrj.com.cn/2019/08/30163528063062.shtml",
    "datetime": "2019-08-30 16:35:03",
    "code": "002030"
  },
  {
    "title": "达安基因：参股子公司获批新三板终止挂牌",
    "href": "http://stock.jrj.com.cn/2019/08/30162428063047.shtml",
    "datetime": "2019-08-30 16:24:00",
    "code": "002030"
  },
  {
    "title": "达安基因2019年上半年净利6051万 保证了主营试剂与仪器设备的销售规模",
    "href": "http://stock.jrj.com.cn/2019/08/29203128057598.shtml",
    "datetime": "2019-08-29 20:31:04",
    "code": "002030"
  },
  {
    "title": "达安基因2019年上半年盈利6051万元 控股子公司业绩下降",
    "href": "http://stock.jrj.com.cn/2019/07/29140527898847.shtml",
    "datetime": "2019-07-29 14:05:36",
    "code": "002030"
  },
  {
    "title": "达安基因董事何蕴韶合计减持483万股 套现约5470万元",
    "href": "http://stock.jrj.com.cn/2019/06/27073827762012.shtml",
    "datetime": "2019-06-27 07:38:05",
    "code": "002030"
  },
  {
    "title": "达安基因：子公司腾飞基因拟申请终止在新三板挂牌",
    "href": "http://stock.jrj.com.cn/2019/06/17161927715007.shtml",
    "datetime": "2019-06-17 16:19:00",
    "code": "002030"
  },
  {
    "title": "达安基因：有用于检验非洲猪瘟的试剂盒产品",
    "href": "http://stock.jrj.com.cn/2019/05/22184727608374.shtml",
    "datetime": "2019-05-22 18:47:00",
    "code": "002030"
  },
  {
    "title": "达安基因一季度净利2826万元 现金流量净额为955万元",
    "href": "http://stock.jrj.com.cn/2019/05/06175527530389.shtml",
    "datetime": "2019-05-06 17:55:17",
    "code": "002030"
  },
  {
    "title": "达安基因去年净利1.02亿元 同比增长18% 董事长何蕴韶年薪72万元",
    "href": "http://stock.jrj.com.cn/2019/04/02090127304568.shtml",
    "datetime": "2019-04-02 09:01:31",
    "code": "002030"
  },
  {
    "title": "达安基因：2018年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2019/03/29232027269598.shtml",
    "datetime": "2019-03-29 23:20:01",
    "code": "002030"
  },
  {
    "title": "达安基因子公司拟在境外投资",
    "href": "http://stock.jrj.com.cn/2018/12/12121426047295.shtml",
    "datetime": "2018-12-12 12:14:39",
    "code": "002030"
  },
  {
    "title": "达安基因：已聚集具有自主创新能力的生物医药企业百余家",
    "href": "http://stock.jrj.com.cn/2018/11/22103025391467.shtml",
    "datetime": "2018-11-22 10:30:00",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前有创投项目约200个",
    "href": "http://stock.jrj.com.cn/2018/11/21104525386667.shtml",
    "datetime": "2018-11-21 10:45:53",
    "code": "002030"
  },
  {
    "title": "达安基因：公司目前有创投项目约200个",
    "href": "http://stock.jrj.com.cn/2018/11/08093425317678.shtml",
    "datetime": "2018-11-08 09:34:23",
    "code": "002030"
  },
  {
    "title": "达安基因：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/30035025274593.shtml",
    "datetime": "2018-10-30 03:50:00",
    "code": "002030"
  },
  {
    "title": "股价连续下挫 达安基因称经营情况未发生重大变化",
    "href": "http://stock.jrj.com.cn/2018/10/16173525210956.shtml",
    "datetime": "2018-10-16 17:35:00",
    "code": "002030"
  },
  {
    "title": "子公司不再纳入报表 达安基因：预计减少今年营收约1.6亿",
    "href": "http://stock.jrj.com.cn/2018/10/13115625198695.shtml",
    "datetime": "2018-10-13 11:56:44",
    "code": "002030"
  },
  {
    "title": "达安基因：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/25005024999432.shtml",
    "datetime": "2018-08-25 00:50:00",
    "code": "002030"
  },
  {
    "title": "达安基因业：上半年净利5946万元 同比微增",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/25075924860139.shtml",
    "datetime": "2018-07-25 07:59:59",
    "code": "002030"
  },
  {
    "title": "达安基因业绩快报：上半年净利同比增2.34%",
    "href": "http://stock.jrj.com.cn/2018/07/24155524856770.shtml",
    "datetime": "2018-07-24 15:55:00",
    "code": "002030"
  },
  {
    "title": "达安基因：参股公司腾飞基因于新三板挂牌交易",
    "href": "http://stock.jrj.com.cn/2018/05/15173024542927.shtml",
    "datetime": "2018-05-15 17:30:00",
    "code": "002030"
  },
  {
    "title": "达安基因：按港交所IPO新规 有子公司符合条件",
    "href": "http://stock.jrj.com.cn/2018/04/25102624447863.shtml",
    "datetime": "2018-04-25 10:26:06",
    "code": "002030"
  },
  {
    "title": "达安基因：按港交所IPO新规 公司有数家子公司及孙公司符合条件",
    "href": "http://stock.jrj.com.cn/2018/04/25101524447785.shtml",
    "datetime": "2018-04-25 10:15:00",
    "code": "002030"
  },
  {
    "title": "【红刊财经】安徽水利、达安基因“零”分红继续？",
    "href": "http://stock.jrj.com.cn/2018/04/14101628697644.shtml",
    "datetime": "2018-04-14 10:16:58",
    "code": "002030"
  },
  {
    "title": "达安基因：参股子公司腾飞基因获批在新三板挂牌",
    "href": "http://stock.jrj.com.cn/2018/03/14165024240631.shtml",
    "datetime": "2018-03-14 16:50:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第010号】",
    "href": "http://stock.jrj.com.cn/2017/08/30000028927965.shtml",
    "datetime": "2017-08-30 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第010号】",
    "href": "http://stock.jrj.com.cn/2017/08/30000031002896.shtml",
    "datetime": "2017-08-30 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第010号】",
    "href": "http://stock.jrj.com.cn/2017/08/30000028065648.shtml",
    "datetime": "2017-08-30 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第009号】",
    "href": "http://stock.jrj.com.cn/2017/07/28000028927970.shtml",
    "datetime": "2017-07-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第009号】",
    "href": "http://stock.jrj.com.cn/2017/07/28000027912059.shtml",
    "datetime": "2017-07-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第009号】",
    "href": "http://stock.jrj.com.cn/2017/07/28000031002894.shtml",
    "datetime": "2017-07-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第008号】",
    "href": "http://stock.jrj.com.cn/2017/06/28000027912058.shtml",
    "datetime": "2017-06-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第008号】",
    "href": "http://stock.jrj.com.cn/2017/06/28000028927969.shtml",
    "datetime": "2017-06-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第008号】",
    "href": "http://stock.jrj.com.cn/2017/06/28000031002895.shtml",
    "datetime": "2017-06-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "基因检测概念股快速走强 达安基因涨逾5%",
    "href": "http://stock.jrj.com.cn/2017/05/22094822510316.shtml",
    "datetime": "2017-05-22 09:48:51",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第006号】",
    "href": "http://stock.jrj.com.cn/2017/04/21000031002892.shtml",
    "datetime": "2017-04-21 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第006号】",
    "href": "http://stock.jrj.com.cn/2017/04/21000027912060.shtml",
    "datetime": "2017-04-21 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第006号】",
    "href": "http://stock.jrj.com.cn/2017/04/21000028927968.shtml",
    "datetime": "2017-04-21 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第005号】",
    "href": "http://stock.jrj.com.cn/2017/03/30000028927967.shtml",
    "datetime": "2017-03-30 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第005号】",
    "href": "http://stock.jrj.com.cn/2017/03/30000031002893.shtml",
    "datetime": "2017-03-30 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第005号】",
    "href": "http://stock.jrj.com.cn/2017/03/30000027912061.shtml",
    "datetime": "2017-03-30 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第001号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000028927963.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第002号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000027912056.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第002号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000031002891.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第003号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000027912057.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第003号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000028927966.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第001号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000027912055.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第002号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000028927964.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第001号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000031002889.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "[达安基因]产品注册公告【2017第003号】",
    "href": "http://stock.jrj.com.cn/2017/02/28000031002890.shtml",
    "datetime": "2017-02-28 00:00:00",
    "code": "002030"
  },
  {
    "title": "达安基因：参股孙公司拟改制设立股份有限公司及申请新三板挂牌",
    "href": "http://stock.jrj.com.cn/2016/08/11181021306913.shtml",
    "datetime": "2016-08-11 18:10:45",
    "code": "002030"
  },
  {
    "title": "[互动]达安基因：募15亿发行 得教育部财政部批准",
    "href": "http://stock.jrj.com.cn/2016/06/16100321075458.shtml",
    "datetime": "2016-06-16 10:03:00",
    "code": "002030"
  },
  {
    "title": "达安基因：投资设立广州市安丞达融资租赁有限公司",
    "href": "http://stock.jrj.com.cn/hotstock/2016/06/01075921022462.shtml",
    "datetime": "2016-06-01 07:59:57",
    "code": "002030"
  },
  {
    "title": "达安基因：拟投资5100万元参与设立互联网小额贷款",
    "href": "http://stock.jrj.com.cn/hotstock/2016/03/31075920765500.shtml",
    "datetime": "2016-03-31 07:59:57",
    "code": "002030"
  },
  {
    "title": "潜伏12年增值11.5亿 达安基因原高管暴富疑点多",
    "href": "http://stock.jrj.com.cn/2015/07/28030819562868.shtml",
    "datetime": "2015-07-28 03:08:25",
    "code": "002030"
  },
  {
    "title": "达安基因“下放”前瞻业务未披露",
    "href": "http://stock.jrj.com.cn/2015/07/28025619562777.shtml",
    "datetime": "2015-07-28 02:56:56",
    "code": "002030"
  }
]